Dupilumab Improves Symptom Control, Health-Related Quality of Life and Work Productivity Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 6-Year Follow-Up Results From the RELIEVE-AD Study. J of Skin. 2025;9(6):s598. doi:10.25251/2a8shm52